{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:41:49Z","timestamp":1790541709493,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T00:00:00Z","timestamp":1350604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2490-12-29","type":"journal-article","created":{"date-parts":[[2012,10,20]],"date-time":"2012-10-20T00:14:23Z","timestamp":1350692063000},"source":"Crossref","is-referenced-by-count":12,"title":["Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia"],"prefix":"10.1186","volume":"12","author":[{"given":"Koichi","family":"Sakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,19]]},"reference":[{"key":"223_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ncpuro1276","volume":"6","author":"Y Kojima","year":"2009","unstructured":"Kojima Y, Sasaki S, Hayashi Y, Tsujimoto G, Kohri K: Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine. Nat Clin Pract Urol. 2009, 6: 44-53. 10.1038\/ncpuro1276.","journal-title":"Nat Clin Pract Urol"},{"key":"223_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1442-2042.2007.01956.x","volume":"15","author":"DA Schwinn","year":"2008","unstructured":"Schwinn DA, Roehrborn CG: \u03b1 1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol. 2008, 15: 193-99. 10.1111\/j.1442-2042.2007.01956.x.","journal-title":"Int J Urol"},{"key":"223_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1442-2042.2010.02518.x","volume":"17","author":"A Komiya","year":"2010","unstructured":"Komiya A, Suzuki H, Awa Y, Egoshi K, Ohnishi T, Nakatsu H, Ohki T, Mikami K, Sato N, Araki K, Ota S, Naya Y, Ichiwaka T: Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective study. Int J Urol. 2010, 17: 555-62. 10.1111\/j.1442-2042.2010.02518.x.","journal-title":"Int J Urol"},{"key":"223_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1464-410X.2006.06030.x","volume":"97","author":"Y Nishino","year":"2006","unstructured":"Nishino Y, Masue T, Miwa K, Takahashi Y, Ishihara S, Deguchi T: Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study. BJU Int. 2006, 97: 747-51. 10.1111\/j.1464-410X.2006.06030.x.","journal-title":"BJU Int"},{"key":"223_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1442-2042.2011.02957.x","volume":"19","author":"M Yoshida","year":"2012","unstructured":"Yoshida M, Kudoh J, Homma Y, Kawabe K: New clinical evidence of silodosin, an \u03b1 (1A) selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms. Int J Urol. 2012, 19: 306-16. 10.1111\/j.1442-2042.2011.02957.x.","journal-title":"Int J Urol"},{"key":"223_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1464-410X.2006.06448.x","volume":"98","author":"K Kawabe","year":"2006","unstructured":"Kawabe K, Yoshida M, Homma Y: Silodosin, a new \u03b11A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int. 2006, 98: 1019-1024. 10.1111\/j.1464-410X.2006.06448.x.","journal-title":"BJU Int"},{"key":"223_CR7","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","volume":"170","author":"AUA Practice","year":"2003","unstructured":"Practice AUA: Guidelines Committee: AUA guideline on management of benign prostatic hyperplasia. Chapter 1. Diagnosis and treatment recommendations. J Urol. 2003, 170: 530-547.","journal-title":"J Urol"},{"key":"223_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1442-2042.2010.02708.x","volume":"18","author":"T Yokoyama","year":"2011","unstructured":"Yokoyama T, Hara R, Fukumoto K, Jo Y, Miyaji Y, Nagai A, Sone A: Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia. Int J Urol. 2011, 18: 225-30. 10.1111\/j.1442-2042.2010.02708.x.","journal-title":"Int J Urol"},{"key":"223_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/j.1442-2042.2006.01535.x","volume":"13","author":"S Hisasue","year":"2006","unstructured":"Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T: Ejaculatory disorder caused by alph-1 adrenoceptor antagonists is not retrograde ejaculation but loss of seminal emission. Int J Urol. 2006, 13: 1311-16. 10.1111\/j.1442-2042.2006.01535.x.","journal-title":"Int J Urol"},{"key":"223_CR10","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2006.06.004","volume":"176","author":"WJG Hellstorm","year":"2006","unstructured":"Hellstorm WJG, Sikka SC: Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers. J Urol. 2006, 176: 1529-33. 10.1016\/j.juro.2006.06.004.","journal-title":"J Urol"},{"key":"223_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/sj.bjp.0701485","volume":"122","author":"N Moriyama","year":"1997","unstructured":"Moriyama N, Nasu K, Takeuchi T, Akiyama K, Murata S, Nishimatsu H, Yano J, Tsujimoto G, Kawabe K: Quantification and distribution of \u03b11-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br J Pharmacol. 1997, 122: 1009-14. 10.1038\/sj.bjp.0701485.","journal-title":"Br J Pharmacol"},{"key":"223_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1442-2042.2008.02136.x","volume":"15","author":"A Nagai","year":"2008","unstructured":"Nagai A, Hara R, Yokoyama T, Jo Y, Miyaji Y: Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography. Int J Urol. 2008, 15: 915-18. 10.1111\/j.1442-2042.2008.02136.x.","journal-title":"Int J Urol"},{"key":"223_CR13","first-page":"763","volume":"51","author":"R Furuya","year":"2005","unstructured":"Furuya R, Hisasue S, Ogura H, Furuya S, Masumori N, Itoh N, Tsukamoto T: Ejaculatory disorder by alpha-1 adrenoceptor antagonist in patients with benign prostatic hyperplasia comparison between naftopidil and tamsulosin. Hinyokika Kiyo. 2005, 51: 763-766.","journal-title":"Hinyokika Kiyo"},{"key":"223_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0090-4295(03)00471-0","volume":"62","author":"CC Schulman","year":"2003","unstructured":"Schulman CC: Lower urinary tract symptoms\/ benign prostatic hyperplasia: minimizing morbidity caused by treatment. Urology. 2003, 62: 24-33.","journal-title":"Urology"},{"key":"223_CR15","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.urology.2010.03.015","volume":"76","author":"Y Homma","year":"2010","unstructured":"Homma Y, Kawabe K, Takeda M, Yoshida M: Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology. 2010, 76: 1446-50. 10.1016\/j.urology.2010.03.015.","journal-title":"Urology"},{"key":"223_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/pcan.2010.46","volume":"14","author":"CG Roehrborn","year":"2011","unstructured":"Roehrborn CG, Kaplan SA, Lepor H, Volinn W: Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH. Prostate Cancer Prostatic Dis. 2011, 14: 143-8. 10.1038\/pcan.2010.46.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"223_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/sj.bjp.0707366","volume":"152","author":"A Sanbe","year":"2007","unstructured":"Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A: Alpha1-adrenoceptors are required for normal males sexual function. Br J Pharmacol. 2007, 152: 332-40.","journal-title":"Br J Pharmacol"},{"key":"223_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/j.1743-6109.2009.01663.x","volume":"7","author":"F Shimizu","year":"2010","unstructured":"Shimizu F, Taguri M, Matsuyama Y, Sase K, Fujime M: Impact of dry ejaculation caused by highly selective alpha1A-blocker: randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men. J Sex Med. 2010, 7: 1277-83. 10.1111\/j.1743-6109.2009.01663.x.","journal-title":"J Sex Med"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2490-12-29\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2490-12-29.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T20:10:23Z","timestamp":1548101423000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/1471-2490-12-29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,19]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["223"],"URL":"https:\/\/doi.org\/10.1186\/1471-2490-12-29","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,19]]},"article-number":"29"}}